Study finds no difference in quality between telehealth, face-to-face communication

Web-based doctor-patient interactions showed no difference in quality when compared to face-to-face communication, according to a study published in the Journal of Medical Internet Research.

With the expansion of telehealth, patients with non-emergency medical needs are choosing to remotely visit physicians. In this study, researchers evaluated each method of communication to see whether patients and physicians are satisfied with each method.The study simulated physician-patient consultations on pelvic organ prolapse with both a face-to-face visit and a screen-to-screen setting. Some 48 consultations were conducted by two medical interns and six simulated patients in four different scenarios.

Results showed no difference in quality between telehealthcommunications and face-to-face visits according to factors of patient-related outcomes, satisfaction, perceived information exchange, interpersonal relationship building and perceived shared decision making. Additionally, researchers noted a patients’ attitude to web-based communication and perceived time and attention correlated with their perceived interpersonal relationship building.

“In this study, the quality of doctor-patient communication, as indicated by information exchange, interpersonal relationship building, and shared decision making, did not differ significantly between Web-based and face-to-face consultations,” concluded first author Kiek Tates, PhD, and colleagues. “Doctors and simulated patients were equally satisfied with both types of consultation medium, and no differences were found in the manner in which participants perceived communicative behavior during these consultations. The findings suggest that worries about a negative impact of web-based video consultation on the quality of patient-provider consultations seem unwarranted as they offer the same interaction quality and satisfaction level as regular face-to-face consultations.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.